A detailed history of Parallel Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parallel Advisors, LLC holds 34,022 shares of BMY stock, worth $1.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
34,022
Previous 32,283 5.39%
Holding current value
$1.9 Million
Previous $1.34 Million 31.34%
% of portfolio
0.04%
Previous 0.03%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $68,968 - $89,993
1,739 Added 5.39%
34,022 $1.76 Million
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $10,988 - $14,466
-273 Reduced 0.84%
32,283 $1.34 Million
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $126,187 - $143,072
-2,630 Reduced 7.47%
32,556 $1.77 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $648,177 - $773,454
-13,370 Reduced 27.54%
35,186 $1.81 Million
Q3 2023

May 20, 2024

SELL
$57.89 - $64.73 $669,034 - $748,084
-11,557 Reduced 19.23%
48,556 $2.82 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $669,034 - $748,084
-11,557 Reduced 19.23%
48,556 $2.82 Million
Q2 2023

May 20, 2024

SELL
$63.71 - $70.74 $259,172 - $287,770
-4,068 Reduced 6.34%
60,113 $3.84 Million
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $259,172 - $287,770
-4,068 Reduced 6.34%
60,113 $3.84 Million
Q1 2023

May 20, 2024

BUY
$65.71 - $74.53 $2.08 Million - $2.36 Million
31,625 Added 97.14%
64,181 $4.45 Million
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $167,757 - $190,275
-2,553 Reduced 3.83%
64,181 $4.45 Million
Q4 2022

Feb 03, 2023

BUY
$68.48 - $81.09 $342,057 - $405,044
4,995 Added 8.09%
66,734 $4.8 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $130 - $77,377
-1,007 Reduced 1.6%
61,739 $4.39 Million
Q2 2022

Aug 01, 2022

BUY
$72.62 - $79.98 $387,500 - $426,773
5,336 Added 9.29%
62,746 $4.83 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $611,234 - $732,924
9,942 Added 20.94%
57,410 $4.23 Million
Q4 2021

Jan 20, 2022

SELL
$53.63 - $62.52 $212,213 - $247,391
-3,957 Reduced 7.69%
47,468 $2.96 Million
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $59,110 - $69,240
999 Added 1.98%
51,425 $3.04 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $276,861 - $301,502
4,472 Added 9.73%
50,426 $3.37 Million
Q1 2021

Apr 23, 2021

BUY
$59.34 - $66.74 $276,405 - $310,874
4,658 Added 11.28%
45,954 $2.9 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $98,619 - $111,754
-1,708 Reduced 3.97%
41,296 $2.56 Million
Q3 2020

Oct 27, 2020

BUY
$57.43 - $63.64 $160,689 - $178,064
2,798 Added 6.96%
43,004 $2.59 Million
Q2 2020

Jul 16, 2020

BUY
$54.82 - $64.09 $462,187 - $540,342
8,431 Added 26.53%
40,206 $2.36 Million
Q1 2020

Apr 27, 2020

BUY
$46.4 - $67.43 $178,176 - $258,931
3,840 Added 13.75%
31,775 $1.77 Million
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $309,924 - $404,268
6,298 Added 29.11%
27,935 $1.79 Million
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $46,277 - $54,868
1,082 Added 5.26%
21,637 $1.1 Million
Q2 2019

Aug 05, 2019

SELL
$44.62 - $49.34 $8,165 - $9,029
-183 Reduced 0.88%
20,555 $932,000
Q1 2019

May 01, 2019

SELL
$45.12 - $53.8 $142,579 - $170,008
-3,160 Reduced 13.22%
20,738 $989,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $171,440 - $222,316
-3,516 Reduced 12.83%
23,898 $1.24 Million
Q3 2018

Nov 01, 2018

BUY
$55.19 - $62.25 $380,866 - $429,587
6,901 Added 33.64%
27,414 $1.7 Million
Q2 2018

Jul 30, 2018

BUY
$50.53 - $62.98 $38,503 - $47,990
762 Added 3.86%
20,513 $1.14 Million
Q1 2018

May 08, 2018

BUY
$59.92 - $68.98 $48,355 - $55,666
807 Added 4.26%
19,751 $1.25 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $128,511 - $140,110
-2,144 Reduced 10.17%
18,944 $1.16 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $1.15 Million - $1.33 Million
20,888 Added 10444.0%
21,088 $1.29 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $1.19 Million - $1.38 Million
-21,625 Reduced 99.08%
200 $13,000
Q2 2017

Aug 07, 2017

BUY
N/A
21,825
21,825 $1.24 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.